International patent for invention regarding immunology. We invented vaccine based on chimeric flagellin. The chimeric flagellin is composed of variable domain of flagellin from bacteria Helicobacter pylori, which serves as antigen, and invariable D0 and D1 domain of flagellin from bacteria Escherichia coli, which activates innate immunity. With vaccine we enable production of antibodies against bacteria Helicobacter pylori and activation of innate immunity.
F.32 International patent
COBISS.SI-ID: 4381466